NGL FINECHEM
Back to Balance Sheet
|
NGL FINECHEM Last 5 Year Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Current Liabilities | - | - | - | - | - |
What is the latest Current Liabilities ratio of NGL FINECHEM ?
Year | Current Liabilities |
---|---|
Mar2024 | - |
Mar2023 | - |
Mar2022 | - |
Mar2021 | - |
Mar2020 | - |
How is Current Liabilities of NGL FINECHEM Trending?
Years | Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | - | 0 | |
Mar2023 | - | 0 | |
Mar2022 | - | 0 | |
Mar2021 | - | 0 | |
Mar2020 | - | - |
Compare Current Liabilities of peers of NGL FINECHEM
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NGL FINECHEM | ₹822.1 Cr | 8.7% | 24.4% | -45.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹401,289.0 Cr | -0.4% | -0.9% | 4.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹181,397.0 Cr | -0.7% | 1.6% | 50.2% | Stock Analytics | |
CIPLA | ₹119,955.0 Cr | -1.7% | -1.1% | -2.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹112,132.0 Cr | -1.1% | 1.6% | 13.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,657.0 Cr | -4.3% | -8% | -4.4% | Stock Analytics |
NGL FINECHEM Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NGL FINECHEM | 8.7% |
24.4% |
-45.3% |
SENSEX | -1.1% |
-0% |
3.2% |
You may also like the below Video Courses